Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Home administration of monoclonal antibodies in severe asthma
NL-OMON27883Active, not recruiting
- Sponsor
- No
- Start
- Jun 2019
- Countries
- 1
01
Overview
Open-label trial in severe asthma (2 arms), sponsored by No. Primary endpoint: Patient satisfaction. Started Jun 2019; status: active, not recruiting.
02
Conditions
severe asthma
Beyond the preview
Go deeper on NL-OMON27883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27883.